Science & Research
Current and Previous Intramural Research Science Program Awards
Center for Biologic Evaluation and Research (CBER)
2009
Indira Hewlett, Ph.D.
In Vitro Studies to Assess Impact of Gender and Co-Infection with Herpes Simplex Virus Type 2 on the Replication and Transmissibility of Major Emerging HIV-1 Variants
Debora Taylor, Ph.D.
The Role of Estrogen in Enhancing Innate Immunity During Viral Infection
2008
Mustafa Akkoyunlu Ph.D.
The Role of Vaccine Adjuvant Mediated TACI Upregulation in SLE
Andrew Dayton, Ph.D.
Effects of B-Estradiol on the Safety of Anti-HIV Drugs
2007
Indira Hewlett, Ph.D.
Evaluation of Gender Differences in Detection, Replication and Transmissibility of Emerging HIV-1 Variants
Deborah Taylor, Ph.D.
The Role of Estrogen in Enhancing Innate Immunity During Viral Infection
2006
Hana Golding, Ph.D., Surender Khurana, Ph.D.
HIV SELECTEST A Novel Assay for Diagnosis of HIV Infections in the Presence of Antibodies Induced by Candidate HIV Vaccines: Evaluation of Gender Bias in Sensitivity and Specificity
2004
Felice D’Agnillo, Ph.D.
Gender Based Differences in the Vascular Response to Anthrax Toxin: Investigation of the Role of Hormones in an In Vitro Human Endothelial Cell Culture System
Andrew Dayton, Ph.D.
Gender Dimorphism in HIV Infection in Primary Macrophages and T-Lymphocytes Kinetics of HIV Replication and Efficacy of Anti-Retroviral Agents
2002
Daniela Verthelyi, Ph.D.
Effect of Sex Hormones on the Immune Response to CpG ODN
2001
Hana Golding, Ph.D., Marina Zaitseva, Ph.D.
Thymic Regeneration and Immune Function Reconstitution in Babies Born to HIV-infected Mothers
1999
Vance Berger, Ph.D.
Improving the Evaluation of Ovarian Cancer Treatment
Carolyn Deal, Ph.D.
Hormone Effects on Pathogenesis & Host Cell Interactions of N. Gonnorrhea
1998
Frederick Miller, M.D., Ph.D.
Silicone Gel-filled Breast Implant Capsules: A Molecular Histologic and Immunophenotypic Study
Emily Shachter, Ph.D.
Improve the Efficacy of Chemotherapeutic Drugs for the Treatment of Breast Cancer
1997
Margaret Bash, M.D., MPH
Antigenic Characteristics and Immunogenicity of Synthetic Peptide Vaccines for the Pathogenic Neisseria: Neisseria meningitides and Neisseria gonorrhea
Hana Golding, Ph.D.
Sexual transmission of HIV-1 in Women and Mother to Infant Transmission: The Importance of HIV-1 Co-receptor Expression on Cerviovaginal Cells and on Cord Blood Cell Subsets
1996
Dennis Klinman, M.D., Ph.D.
A Novel Approach to the Treatment of Lupus Nephritis
Penelope Robbins, Ph.D.
Human Cytotoxic T Lymphocyte Recognition of Papilloma Virus
Emily B. Shachter, Ph.D.
Administration of Thrombolytic Therapy to Women with Acute Myocardial Infarction: Is It Too Late?
Giovanna Tosato, M.D.
IP-10: A Potential New Therapeutic for Breast Cancer
1995
David S. Finbloom, M.D.
Cytokine Induced Activation of the Jak Kinase/STAT Transcription Factor Pathway in Immune Cells (Monocytes and Lymphocytes) of Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus
Basil Golding, M.D.
Induction of Mucosal Immunity to Protect Females from HIV-1
Dennis Klinman, M.D., Ph.D.
Hormonal Regulation of Cytokine-producing Cells in Women with Systemic Lupus Erythematosus
Philip R. Krause, M.D.
Development of a Method to Evaluate the Effect of Vaccines and Antiviral Therapy on Latent Viral Burden in an Animal Model of Genital Herpes
Carol B. Trapnell, M.D.
The Effect of Thalidomide on the Pharmacokinetics of Ethinyl Estradiol and Norethindrone
1994
Frederick W. Miller, M.D., Ph.D.
Immunogenetic Risk Factors for Silicone-associated Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance
Michael A. Norcross, M.D.
Women and AIDS Transmission
Carol B. Trapnell, M.D.
An Open-label, Randomized, Cross-over, Feasibility Study to Quantify the Retention of Vaginally Administered Nonoxynol-9 (N-9) Foam in Premenopausal Women
Center for Drug Evaluation and Research (CDER)
2009
Luis Valerio, Jr., Ph.D.
Computational Human Health Effects Study to Assess the Safety of Botanical Extracts Widely Used by Women in the United States for Treatment of Menopausal Symptoms
Karen Feibus, M.D.
Ethics Roundtable: The Ethics of Studying Drugs and Biologics in Pregnant Women
2008
Christine Garnett, Ph.D., Philip Dinh, Ph.D.
Gender-Related Differences in QT Effects and Torsade de Pointes Potential of Drugs
Christy John, Ph.D.
Qualifying Imaging Biomarkers to Monitor Neoadjuvant Chemotherapy in Breast Cancer Patients to Identify Responders Using Positron Emission Tomography (PET)
Sandra Kweder, M.D., Susan Cummins, M.D.
The Athma and Allergy Medications in Pregnancy Surveillance System (AAMPSS) Demonstration Project
Nakissa Sadrieh, Ph.D.
Evaluating the Effects of Over-the-Counter Skin Products, such as Sunscreen, on the Absorption of Dermally Applied Estradiol, in an In- Vitro and an In-Vivo Model
Anna Szarfman, Ph.D.
Detection and Confirmation of Gender Related Safety Signals Using the Electronic Healthcare Data from the Department of Defense
Lee Zhang Ph.D.
Safer use of Narcotics in Pregnant and Lactating Women
2007
Shashi Amur, Ph.D
Gender, Ethnicity and Pharmacogenomics in Systemic Lupus Erythematosus (SLE)
Audrey Gassman, M.D.
Workshop: Drugs in Pregnancy
Yongsheng Yang, Ph.D.
Identification of Sex Differences in Adverse Outcomes for New Molecular Entities (NMEs) Approved from 2000-2002
2006
Shashi Amur, Ph.D.
Gender Differences and Impact of Pharmacogenomics in Rheumatoid Arthritis
Angela Men, Ph.D., Shashi Amur, Ph.D.
Impact of Gender Analysis and Pharmacogenomics on Clinical Efficacy, Safety, and Pharmacokinetics of Drugs Used for the Treatment of Alzheimer’s Disease.
Roshni Ramchandani Ph.D., Edwin P. Rock, M.D., Ph.D.
Quantitative Tumor Size- Survival Relationship in Oncology Clinical Trials
Ohidul Siddiqui, Ph.D.
Statistical Analysis of Gender Specific Data from New Drug Application (NDA) Submissions
Greg Soon, Ph.D.
Women in HIV Trials: A Comprehensive Review and Meta-Analysis
Mary Willy, Ph.D.
Drug Use in Pregnancy
Yongsheng Yang, Ph.D.
Participation of Women in Clinical Trials and Gender Analysis of Data in Original NDAs Approved 2000-2002.
2005
Hyojong Kwon, Ph.D., Robert Lionberger, Ph.D.
Sex Difference Dependent Drug-drug Interactions of Anti-HIV Therapeutics
2004
Ellen Tabak, Ph.D, Leslie Wheelock, Ph.D.
Gender Differences in the Willingness to Read and Follow Patient Information
2003
Jogarao Gobburu, Ph.D.
Are Women at Higher Risk from Proarrhythmic Drugs?
Eugene Herman, Ph.D.
Discovery and Evaluation of Interspecies Biomarkers to Monitor the Early Onset and the Progression of Cardiovascular Toxicity Associated with Tiazolidinedione Compounds Used in the Treatment of Type 2 Diabetes
John. Koerner, Ph.D.
Electrophysiological Characterization of Several Torsadogenic Drugs in Isolated Rabbit Hearts
2002
Mei Ling Chen, Ph.D.
Gender Effect on the Assessment of Bioavailability and Bioequivalence Gender Differences in Intestinal Levels of CYP3A4, CYP 3A5, P-gP and MRP
2001
Eugene A. Herman, Ph.D., Frank Sistare Ph.D.
Discovery and Evaluation of Interspecies Biomarkers to Identify and Characterize the Cardiotoxic Effects of Herceptin, a Novel Antibody Used in the Treatment of Breast Cancer
Shew-Mei Huang, Ph.D., Steven Hall Ph.D.
The Effects of Echinacea on Cytochrome P450 Enzymes and Oral Contraceptives
Shinya Ito, M.D., Gerald Fetterly, Ph.D.
Drug Update in Human Mammary Gland Epithelia
Patrick J. McNamara, Ph.D., Gerald Fetterly, Ph.D
Development of a General Approach for the Investigation of Drug Transfer in Breast Milk: In Vitro Assessment of Drug Distribution into Breast Milk
2000
Debra Birnkrant, M.D., Ajaz Hussain, Ph.D.
Vaginal Volume: Optimizing Vaginal Deployment of Topical Microbicides
Ann Farrell, M.D., Lilia Talarico, M.D.
Women's Participation in Clinical Drug Trials for Unstable Angina and Myocardial Infarction
Ronald Honchel, Ph.D., Frank Sistare, Ph.D.
Evaluation of the Tg.AC Transgenic Mouse as a Model for Predicting the Photocarcinogenicity of Pharmaceuticals and Cosmeceuticals
1999
Chandra Sahajwalla, Ph.D.
Evaluation of In-vitro Mechanistic Basis for Gender Dependant Differences in Pharmacokinetics
Mary Willy, Ph.D.
Post-marketing Drug Risk Assessment Using the ARAMIS Database in RA Patients
1998
Kathryn Aiken, Ph.D.
Pregnancy Labeling Taskforce Focus Group testing (co-funded by NIH ORWH)
Shiew Mei Huang, Ph.D., Robert Branch, Ph.D.
Gender Differences in P450 Activities and their Implications (co-funded by NIH ORWH)
Thomas Layloff, Ph.D.
Chemical Characteristics of Conjugated Estrogens
Ralph Lillie, RPh
Adverse Events Reporting System (AERS): Risk assessment, Compliance & Management
Carolyn McCloskey, M.D., MPH
Teratogen Surveillance
Ana Szarfman, M.D., Ph.D.
Data Mining Techniques for Identifying Potential Serious Drug Interactions in Women
Ana Szarfman, M.D., Ph.D., Raymond L. Woosley, M.D., Ph.D.
Variations in the Drug-induced QT Interval Prolongation During the Menstrual Cycle (Co-funded by NIH ORWH)
1997
John Strong, Ph.D.
Contribution of Estrogen Components to the Efficacy of Conjugated Estrogens - Preliminary
Analytical Chemistry
Ana Szarfman, M.D., Ph.D.
Visualization Tools for Studying Gender Differences
1996
Donna A. Volpe, Ph.D.
In Vitro Prediction of Time to Neutropenic Nadir: Anti-neoplastic Alkylating Agents as Prototype Drugs
1995
Edwin J. Matthews, Ph.D.
Estimation of Reproductive Toxicity of Pharmaceuticals Using QSAR Software Programs
Bruce V. Stadel, M.D.
Hormone Replacement Therapy in Women with a Previous Diagnosis of Endometrial Cancer
Ellen R. Tabak, Ph.D.
Gender Differences in Perception of Risks Communicated by Prescription and Over-the-counter Drug Labels, Phase I and II
Brenda Vaughan, M.D.
Thalidomide: Are There Gender Disparities in Treatment Outcome and Non-teratogenic Adverse Effects?
Sheila Weiss, Ph.D.
Profile of Drug Use in Pregnancy
1994
Lou Cantillina, M.D.
Women in Clinical Trials Terfenadine/Oral Contraceptive Study
David Flockhart, M.D., Ph.D.
Comparison of the Beta-adrenergic Antagonist Actions of Propranolol in Men and Women
Raymond L. Woosley, M.D., Ph.D.
Comparison of the Potassium Channel Blocking Actions of Quinidine in Men and Women
Center for Device and Radiological Health (CDRH)
2009
Srinidhi Nagaraja, Ph.D., Maureen Upton, Ph.D.
Do Vertebroplasty Procedures Increase the Risk of Adjacent Level Vertebral Fractures in Osteoporotic Women
Kathryn O’Callaghan, B.S.
Analysis of Sex-Differences in Cardiac Resynchronization Therapy Devices: Inclusion, Adverse Events, and Outcomes
Peter Goering, Ph.D., Kevin McBryde, M.D.
Development of Urinary and Serum Biomarkers of Kidney Damage in Patients with Systemic Lupus Erthematosus Nephritis
Dinesh Patwardhan, Ph.D.
Sex-Based Differences in the Safety of Drug-Eluting Stents Containing Bioresorbable Materials
Aldo Badano, Ph.D.
Development of a Tissue-Mimicking Physical Phantom and Quantitative, Assessment Toos for Standardizations, Optimization, and NSF Risk Reduction in Dynamic Contrast-Enhanced MRI of the Breast
Iacovos Kyprianou, Ph.D.
Women’s Radiation dose and Excess Cancer Risk Associated with X-Ray Computed Tomography Scans: Quantification and Risk-Mitigation Strategies
2008
Kish Chakrabarti, Ph.D.
Dose and Image Quality Optimization in Full Field Digital Mammography
Bedri Karakas, Ph.D.
A Safe and Sensitive Assay to Evaluate Response and Relapse using DNA Mutation Biomarkers and Bead Based Emulsion PCR in Women with Breast Cancer
Cara Krulewitch, CNM, Ph.D.
The Safety and Effectiveness of Surgical Mesh Implant Use in Uro-Gynecologic Surgery for Soft Tissue Augmentation
Kathryn M. O’Callaghan, B.S.
Workshop: Guidance for the Study and Analysis of Sex Differences in the Clinical Evaluation of Cardiovascular Medical Devices
Subok Park, Ph.D.
Patient Safety and Imaging Performance of Three-Dimensional (3D) X-Rays Systems for Detection of Breast Cancer
Cunlin Wang, M.D., Ph.D.
Gender Differential in National Estimates for Medical Device-Associated Adverse Events (MDAEs) from Emergency Departments
2007
Soma Kalb, Ph.D.
Factors Accelerating the Progression of Heart Failure (HF) in Women: Implications for Drug Interactions with Medical Devices
Dinesh Patwardhan, Ph.D.
The Impact of Sex-Based Differences in Atherosclerotic Plaque on the Response to Drug Eluting Stent Implantation
Art Sedrakyan, MD, PhD
Real-World Outcomes of Drug-Eluting Stents
2006
Jove Graham, Ph.D.
Evaluating the Effectiveness of Vertebroplasty for Improving the Mechanical Properties of the Spine in Patients with Osteoporosis.
Kathryn O’Callaghan B.S.
Evaluation of Availability and Quality of Information Available on Females Included in Mechanical Device Implant Trials.
2005
Iacovos Kyprianou, Ph.D., Kyle Myers, Ph.D.
Implications of Gender-based Differences in Cardiovascular Disease on Imaging for Treatment and Diagnosis
Azadeh Shoaibi, M.S., MPH, Dale Tavris M.D. MPH
Assessment of the Accuracy of the Troponin Assay and the Diagnosis of Myocardial Infarction by Gender/ How Gender Influences Treatment
2004
Jove Graham, Ph.D.
Development of Guidelines for Evaluating the Appropriateness of Vertebroplasty Surgery for Patients with Osteoporosis
2003
Melvin Stratmeyer, Ph.D.
Cardiovascular Effects of Ultrasound Contrast Agents in Intact and Ovariectomized Female Animals
2002
Dale Tavris, M.D. MPH
Incidence and Attributable Risk of Serious Adverse Events and Death Associated with the Use of Homeostasis Devices by Gender
2001
Rosalie Elespuru, Ph.D., Roselie Bright, Sc.D.
Developing a Diagnostic Gene Expression Profile for Latex Sensitivity Using Microarrays
Sharon Miller M.S., Janusz Beer, Ph.D.
Optimization of UV Exposure Patterns Maximizing Perceived Benefits While Minimizing Photocarcinogenic/photo-aging Effects
2000
Ronald Kaczmarek, M.D.
Surveillance of Sex-specific Utilization, Morbidity, and Mortality Associated with Transmyocardial Revascularization
Richard Kotz, Ph.D.
A Study to Evaluate the Consistency of T-scores Among Ultrasound Bone Measurement Devices and the Usefulness of these Devices for Monitoring Bone Status
1999
Rosalie Bright, Sc.D.
Active Postmarketing Surveillance Methods: A Hospital Pilot
Robert Navario, Ph.D, S.L.Brown, M.D.
Assessment of Consumer Understanding of Barrier Contraception and Tampon Labeling: Focus Group Studies
1998
Patricia Dubill, Ph.D.
Abrasion Testing of Breast Implants
James Karanian, Ph.D.
Ovarian Steroids and Cardiovascular Disease the Role of Gender in the Effectiveness of Interventional Medical Devices
Harvey Rudolph, Ph.D.
Accelerated Aging Studies of Condoms/condom Materials
Harvey Rudolph, Ph.D.
Flow Studies and the Use of a Waveguide in Cardiovascular Devices
Keith Wear, Ph.D.
Development and Validation of Ultrasonic Backscatter Measurement for Bone Density Assessment
1997
S. Lori Brown M.D.,
Institute of Medicine Study: A Study of Safety of Silicone Breast Implants
S. Lori Brown, M.D.
Protocol for a Study of Breast implant rupture
Rosalie Bright, Sc.D.
Mammography Breast Cancer Screening Rates Among Disadvantaged Women within a Pre-Paid Health Care System
Robert Jennings, Ph.D.
Optimization of mammography
Steven Lascher, DVM, MPH
A Comparison of Gender Specific Utilization of Implantable Cardioverter Defibrillator Therapy and Post-implantation Survivability
Danica Marinac-Dabic, M.D.
Epidemiology of Medical Devices in Women (conference)
1996
Marwood N. Ediger, Ph.D.
Development of a Safe, Economical Assay for Silicone Containment in Blood and Tissue
Melvyn Greberman, M.D., MPH
The Transfer of Defense, Intelligence and Space Technologies for the Early Detection and Control of Cancers in Women (conference)
Matthew R. Myers, Ph.D.
A Computer Model for Simulating Virus Transport through Barriers
1995
Danica Marinac-Dabic, M.D.
Gender Differences in Early and Long-term Results of Coronary Angioplasty with Palmaz/Schatz Stent
Kyle Myers, Ph.D.
Non-invasive Assessment of Silicone Migration from Gel-filled Breast Implants
Paula G. Silberberg, M.D.
Contraceptive Efficacy Table for Uniform Contraceptive Labeling-- a Consumer Focus Group Study - Part I and II
Keith A. Wear, Ph.D.
Application of Ultrasonic Tissue Characterization to Diagnosis of Bone Disease
1994
John Langone, Ph.D.
Silicone Gel Alternatives Workshop
Carol Sierka, B.S.
Consumer Brochure on Mammography
Development of MQSA Speaker Kits
Center for Food Safety and Nutrition (CFSAN)
2008
Thomas Flynn, Ph.D.
Evaluation of Inflammation and Sex Hormones as Biological Factors that May Contribute to Gender Differences in Susceptibility to Chemical-Induced Liver Injury – Studies Using Human Liver Cells in Culture
2007
Elizabeth Calvey Ph.D., Marjorie Davidson, Ph.D.
Understanding Consumer Behavior Associated with Changing Messages on Listeria monocytogenes and Food Safety
2004
Maria Lorenzo, DVM, Mona S. Calvo, Ph.D., Dennis Hinton, Ph.D. Susan B. Harper,
Sabine Francke-Carroll, and Rene K. O’Neill
Do Phytoestrogens Modify the Allergic Response to Food Allergens in the Newly Validated, Highly Sensitive, In-Bred Asthmatic Rat Model
Robert Sprando, Ph.D.
Developmental Toxicity of Androstenedione in Rats
2002
Robert Sprando, Ph.D.
Characterization of the Effect of Pre-pubertal and Pubertal Exposure of Androstenedione on Female Reproductive Health
2000
Jeffrey Yourick, Ph.D.
Teratogenic Potential of Cosmetic Products Containing Retinol (Vitamin A) and Retinyl Palmitate-Phase I
1999
Robert Bronaugh, Ph.D.
Potential Exposure of Women to Estrogens, Phytoestrogens and Xenoestrogens through Cosmetic Products
1998
Kenneth T. Durham, Ph.D.
CFSAN's Internet Initiative: Infra-structure Support
Nancy Slifman, M.D., MPH
Contaminants in Dietary Supplements Frequently Used in Women
1997
Shirley R. Blakely, Ph.D.
Obesity: Its Effect on Antioxidant and Estrogen Metabolism
Mona S. Calvo, Ph.D.
Vitamin K Status of Non-Hispanic Black and White Girls and Young Adult Women: Direct Measure of Serum Phylloquinone Levels and Measurement of a New Functional Endpoint in Serum Samples from NHANES III
1996
Kenneth T. Durham, Ph.D.
CFSAN's Women's Health Internet Initiative- Phase II
Thomas J. Sobotka, Ph.D.
Screening for Nervous System Dysfunction in Offspring of Dams Exposed to Natural Food Contaminates During Pregnancy
Ruth A. Welch, Ph.D.
Women's Health Information Line
1995
Kenneth T. Durham, Ph.D.
CFSAN's Women's Health Internet Initiative - Phase I
Mary L. Tortorello, Ph.D.
Rapid Method for Detection and Enumeration of Listeria Monocytogenes in Foods
Ruth Welch Ph.D., Carole Schiffman Ph.D.
Osteoporosis Prevention in Adolescent Girls
1994
John E. Bailey, Ph.D.
Cosmetics Initiatives Alpha Hydroxy Acids (AHAs)
John E. Bailey, Ph.D.
AHA Literature Search
Sara B. Fein, Ph.D.
Infant Feeding Practices Study
Center for Veterinary Medicine (CVM)
2000
Jurgen von Bredow, Ph.D.
Use of a Unique Animal Model to Study Placental Milk Transfer of Ciprofloxicin from the Dam to the Offspring During the Perinatal Period
1995
John Leighton, Ph.D.
A Novel Molecular Approach to Risk Assessment of Hormonally Active Compounds
National Center for Toxicological Research (NCTR)
2009
Mark Hart, Ph.D.
Application of Co-Culture and Simulated Vaginal Models to Elucidate in the Inhibitory Properties of Naturally Occurring and Bioengineered Strains of Lactobacillus Toward Toxic Shock Syndrome Toxin-1 Producing Strains of Staphylococcus Aureus
Weida Tong, Ph.D.
Development of an FDA Resource for Sex Difference-Related Pharmacogenomics data Review-Phase II
Beverly Lyn-Cook, Ph.D.
Women’s Health Initiative Seminar Series and Workshop at NCTR
Beverly Lyn-Cook, Ph.D., Athena Starland-Davenport, Ph.D.
Inactivation of UDP-Glucuronosyltransferases (UGTs) in Human Breast and Endometrial Tissues: Accessing Cancer Risk, Tamoxifen Safety and Toxicity
2008
Huizhong Chen, Ph.D.
Risk Assessment of Human Skin Microflora Metabolism of Synthetic Azo Colorants used in Women’s Cosmetics
Beverly Lyn-Cook, Ph.D.
Genotyping of Transporter Genes Associated with Gender Differences and Promoter Methylation Profile of UGT1A1 in Human Liver: A Mean of Assessing Safety and Toxicity of Chemotherapeutic Drugs
Doug Wagner, Ph.D.
Gene Expression Responses of Estrogen-Primed Vaginal Epithelial Cells After Contact With Candida albicans and Probiotic Lactobacilli
2007
Beverly Lyn-Cook, Ph.D., Neera Gopee, Ph.D.
Sex differences in Systemic Lupus Erythematosus (SLE): Effects of a single nucleotide polymorphism (SNP) in the prolactin (PRL) gene on individual response to prasterone therapy
Baitang Ning, Ph.D.
Mechanisms of Gender Differences in Aspirin Effects:
Metabolizing Enzymes and Therapeutic Targets
Weida Tong, Ph.D.
Development of a FDA Resource for Improved Efficiency of Sex Difference Related Pharmacogenomic Data Analysis and review
2006
Varsha Desai, Ph.D.
Molecular Mechanisms Underlying Gender-associated Differences in the Adverse Reactions to the Anti-retroviral Agent, Zidovudine (AZT) Role of Mitochondrial Toxicity
Christopher Elkins, Ph.D., Mark Hart, Ph.D.
Protective Effect of Vaginal Lactobacillus Species Against Staphylococcus Aureus-mediated Toxic Shock Syndrome
Beverly Lyn-Cook, Ph.D.
Sex Differences in Chemotherapeutic Toxicity: Profiling of Transporter Genes in Human Liver
2005
James Fuscoe, Ph.D.
Systems Biology Approach to Evaluate Sex Differences in the Heart of a Rat Model
2002
Angela Harris, Ph.D.
Development and Characterization of Conditionally Immortalized Human Primary Hepatocyte Cell Lines From Female And Male Donors -- Phase I
2000
Anane Aidoo, Ph.D.
Evaluation of the Effects of Daidzein And Genistein on The Genotoxic and Carcinogenic Activity of the Model Mammary Carcinogen 7,12-Dimethylbenz(A) Anthracene (DBMA) in Ovariectomized Transgenic Big Blue Rats
Vasily Dobrolovsky, Ph.D.
Evaluation of the Tk Knockout Mouse as a Model of Systemic Lupus Erythematosus
1999
Dean Roberts, Ph.D.
Antigenic Biomarkers of Estrogen Catechol Metabolism for Post-Market Surveillance of Oral Contraceptives and HRT's
1998
Patricia Thompson, Ph.D.
In-Vivo Modeling Of Steroid-Mediated Gender Effects in Drug Metabolism (Phase I and II)
1997
Christine B. Ambrosone, Ph.D.
Breast Cancer in African-American Women: Metabolic Modification of Dietary and Hormonal Risk Factors
S. Jill James, Ph.D.
Molecular and Metabolic Determinants of Maternal Risk and Progression of Down's Syndrome Potential for Nutritional Intervention
William H. Tolleson, Ph.D.
Development Of In Vitro Human Cell Culture Systems to Screen Compounds Suspected To Have Estrogenic or Anti-Estrogen Activity
1996
Frederick A. Beland, Ph.D.
DNA Adducts of Tamoxifen
Darnell Carlton Jackson, Ph.D.
Development of an Estrogen Knowledge Base for Research and Regulation
Daniel M. Sheehan, Ph.D.
Experimental Assessment of Environmental Estrogens
1995
S. Jill James, Ph.D.
Mechanism of Immunotoxicity and Carcinogenicity Associated With Silicone Breast Implants
Randal Streck, Ph.D.
Mechanism of Tamoxifen Development Toxicity and Neoplasia Tamoxifen Effects on the Rat Uterine Insulin Like Growth Factor System
1994
Dan Sheehan, Ph.D.
Effects of Toremifene and ICI 182,780 on Rat Uterine Growth
Office of External Affairs (OEA)
1995
Peter Rheinstein, M.D., JD
Research Involving Human Subject Committee (RIHSC)
Teresa Toigo, RPh, MBA
Development and Expansion of a Pilot Tracking System for Monitoring the Barriers to the Enrollment of Women in Clinical Trials
1994
Conference on STD Clinical Trials Workshop (NIH and OEA)
April 6-8 1994
Office of Regulatory Affairs (ORA)
2007
Lesley Kerr, Ph.D.,
Development of a Rapid Version of the Tampon Test Method Based on 21CFR801.430
Phyllis Wilson, Ph.D.,
Development and Validation of an HPLC Method for the Simultaneous Determination of Estradiol, Estriol, Estrone and Progesterone in Pharmaceutical Preparations
2000
Jeffery Archer, M.S.
Analysis of Dioxins/Furnas (17 congeners) Levels in Tampons
1998
Lesley Kerr, Ph.D.
Development and Validation of a Universal Water Leak Test Method for Barrier Contraceptives
1995
Barbara Ward-Groves, MPH
Mammography Quality Standards Act Facilities Workshop
Office of the Commissioner (OC)
2008
Steven Tucker, Ph.D,
Effects of Proposed Revisions to the Regulations Implementing the Mammography Quality Standards Act
2007
Lonnie Smith
SPL XML Tagging
1994
OWH Small Grants Program
Workshop: FDA-regulated Products and Pregnant Women